falls under 1st generation drug delivery system (Brown et al.
The company looks forward to exploring a new field of CNS with the systemic transdermal patch
11 October 2011 - US Zosano Pharma Inc and Japanese Asahi Kasei Pharma Corporation, or AKP, part of Asahi Kasei Corporation (TYO:3407), said on Monday they have signed a long-term strategic partnership deal for the development, commercialisation and supply of a weekly transdermal patch
formulation of Teribone (teriparatide acetate), AKP's formulation of human parathyroid hormone (human PTH 1-34), for the treatment of osteoporosis patients with a high risk of fracture.
and Eli Lilly and Company to develop and commercialize a novel daily transdermal patch
delivering sustained levels of exenatide (currently marketed as Byetta[R]).
The primary objective of the Phase Ib study is to compare systemic levels of oxycodone for the two transdermal patch
candidates, the matrix and reservoir systems.
The exenatide transdermal patch
is an investigational product designed to be applied once per day to provide sustained levels of exenatide for people with type 2 diabetes.
Drugs in Development for Transdermal Patch
Hollingsworth will provide an overview of the company and NuPathe's innovative therapeutic products, including Zelrix[TM], a transdermal patch
for the treatment of acute migraine.
Novartis has decided to divest Habitrol, its private label nicotine replacement therapy (NRT) transdermal patch
business in the US, which was laid as a condition to gain FTC approval for the consumer healthcare JV.
announced today the completion of the development of its once-a-week Huperzine A transdermal patch
for the treatment of Alzheimer's disease (AD).
The timed release of CBD in the Re-Med patch represents a new generation of transdermal patch
technology that combines superior bioavailability and excellent absorption rates with the highest effective levels of key nutritional supplements.
Altea Therapeutics is an emerging specialty pharmaceutical company developing and commercializing products based on a new transdermal patch
technology that can deliver therapeutic levels of water-soluble small drugs, therapeutic proteins, carbohydrates, and vaccines through the skin in a convenient, painless and cost-effective manner.